ANANDA Scientific Announces First Patient Enrolled in the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

GREENWOOD VILLAGE, Colo. and LOS ANGELES, July 26, 2022 /PRNewswire/ -- ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced the first patient enrolled in the clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol (CBD) in...

Click to view original post